Predictive Oncology (POAI) Expected to Announce Earnings on Thursday

Predictive Oncology (NASDAQ:POAI) is anticipated to release its earnings data before the market opens on Thursday, March 27th. Analysts expect Predictive Oncology to post earnings of ($0.25) per share and revenue of $0.35 million for the quarter.

Predictive Oncology Price Performance

POAI opened at $1.13 on Thursday. The stock has a market capitalization of $7.74 million, a PE ratio of -0.37 and a beta of 1.22. The firm’s fifty day moving average price is $1.36 and its 200 day moving average price is $1.00. Predictive Oncology has a 12-month low of $0.55 and a 12-month high of $3.06.

Predictive Oncology Company Profile

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.